Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer

Antoinette R. Tan, Xiaowei Yang, Arlene Berman, Suoping Zhai, Alex Sparreboom, Allyson L. Parr, Catherine Chow, Jaime S. Brahim, Seth M. Steinberg, William D. Figg, Sandra M. Swain*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences